SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-044128
Filing Date
2020-09-21
Accepted
2020-09-21 16:30:51
Documents
11
Period of Report
2020-09-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ITEM 1.01 atrs-8k_20200915.htm   iXBRL 8-K 42583
2 EX-10.1 SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT atrs-ex101_6.htm EX-10.1 30649
  Complete submission text file 0001564590-20-044128.txt   210542

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA atrs-20200915.xsd EX-101.SCH 5796
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE atrs-20200915_lab.xml EX-101.LAB 19478
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atrs-20200915_pre.xml EX-101.PRE 11645
6 EXTRACTED XBRL INSTANCE DOCUMENT atrs-8k_20200915_htm.xml XML 3549
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32302 | Film No.: 201186576
SIC: 3841 Surgical & Medical Instruments & Apparatus
Office of Life Sciences